GGrantIndex
← Leaderboards

Wen-Hwa Lee

Baylor College Of Medicine

$10,566,748
Attributed
$10,566,748
Total exposure
12
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY200514
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14

Funding mix

By agency

NIH$14,292,884 · 13

By mechanism

R01$8,971,189 · 5
P01$3,907,623 · 4
T32$1,394,623 · 1
P41$19,449 · 2
P50$0 · 1

Top collaborators

No co-investigators on record.

Most similar at Baylor College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Laboratory Mouse

Research focus

Laboratory MouseNeoplasm /Cancer GeneticsGene TargetingBrca GeneMolecularGenetically Modified AnimalsBaseTumor Suppressor ProteinsBreast NeoplasmsTumorRetinoblastoma ProteinCarcinogenesisGene ExpressionDna RepairTumor Suppressor GenesMediatingCell CycleBiologicalDisease /Disorder ModelPhosphorylationPlayGene MutationMalignant NeoplasmsGenome Stability

Grant awards (58)

Hec1 Network as Molecular Therapeutic Targets$345,129
R01 · FY2014 · CA · contact PI
Hec1 Network as Molecular Therapeutic Targets$334,456
R01 · FY2013 · CA · contact PI
Hec1 Network as Molecular Therapeutic Targets$355,804
R01 · FY2012 · CA · contact PI
Mitochondrial Roles of the SUV3 in Premature Aging and Cancer$289,934
R01 · FY2012 · AG · contact PI
Transcriptional Role of BRCA1 in Breast Cancer$261,352
R01 · FY2012 · CA · contact PI
Hec1 Network as Molecular Therapeutic Targets$355,804
R01 · FY2011 · CA · contact PI
Translational Research in Cancer Genomic Medicine$304,146
T32 · FY2011 · CA · contact PI
Mitochondrial Roles of the SUV3 in Premature Aging and Cancer$290,982
R01 · FY2011 · AG · contact PI
Transcriptional Role of BRCA1 in Breast Cancer$263,029
R01 · FY2011 · CA · contact PI
Hec1 Network as Molecular Therapeutic Targets$366,808
R01 · FY2010 · CA · contact PI
Translational Research in Cancer Genomic Medicine$314,572
T32 · FY2010 · CA · contact PI
Mitochondrial Roles of the SUV3 in Premature Aging and Cancer$303,683
R01 · FY2010 · AG · contact PI
Transcriptional Role of BRCA1 in Breast Cancer$272,694
R01 · FY2010 · CA · contact PI
PNPASE COMPLEX$10,750
P41 · FY2010 · RR · contact PI
Mitochondrial Roles of the SUV3 in Premature Aging and Cancer$307,598
R01 · FY2009 · AG · contact PI
Transcriptional Role of BRCA1 in Breast Cancer$273,471
R01 · FY2009 · CA · contact PI
Translational Research in Cancer Genomic Medicine$246,479
T32 · FY2009 · CA · contact PI
PNPASE COMPLEX$8,699
P41 · FY2009 · RR · contact PI
Hec1 network as molecular therapeutic targets$343,708
R01 · FY2008 · CA · contact PI
Mitochondrial Roles of the SUV3 in Premature Aging and Cancer$307,366
R01 · FY2008 · AG · contact PI
Translational Research in Cancer Genomic Medicine$306,104
T32 · FY2008 · CA · contact PI
Transcriptional Role of BRCA1 in Breast Cancer$273,024
R01 · FY2008 · CA · contact PI
Hec1 network as molecular therapeutic targets$429,266
R01 · FY2007 · CA · contact PI
Translational Research in Cancer Genomic Medicine$223,322
T32 · FY2007 · CA · contact PI
Hec1 network as molecular therapeutic targets$409,936
R01 · FY2006 · CA · contact PI
BRCA1 and Transcriptional Control in DNA Damage Response$265,071
R01 · FY2006 · CA · contact PI
Hec1 network as molecular therapeutic targets$333,815
R01 · FY2005 · CA
BRCA1 and Transcriptional Control in DNA Damage Response$270,560
R01 · FY2005 · CA
Hec1 network as molecular therapeutic targets$333,338
R01 · FY2004 · CA
BRCA1 and Transcriptional Control in DNA Damage Response$269,670
R01 · FY2004 · CA
DNA REPAIR AND TUMOR SUPPRESSOR GENES$711,594
P01 · FY2003 · CA
DNA REPAIR AND TUMOR SUPPRESSOR GENES$588,502
P01 · FY2003 · CA
BRCA1 and Transcriptional Control in DNA Damage Response$154,530
R01 · FY2003 · CA
BRCA1 and Transcriptional Control in DNA Damage Response$110,960
R01 · FY2003 · CA
DNA REPAIR AND TUMOR SUPPRESSOR GENES$1,229,276
P01 · FY2002 · CA
BRCA1 and Transcriptional Control in DNA Damage Response$257,255
R01 · FY2002 · CA
CANCER SUPPRESSION BY THE RETINOBLASTOMA GENE$166,650
R01 · FY2002 · CA
CANCER SUPPRESSION BY THE RETINOBLASTOMA GENE$123,125
R01 · FY2002 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2002 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2002 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2002 · CA
CORE--ANIMAL$0
P01 · FY2002 · CA
BRCA GENES AND DNA REPAIR MACHINERY$0
P01 · FY2002 · CA
BRCA1 MALFUNCTION IN BREAST CANCER$0
P01 · FY2002 · CA
DNA REPAIR AND TUMOR SUPPRESSOR GENES$1,196,764
P01 · FY2001 · CA
CANCER SUPPRESSION BY THE RETINOBLASTOMA GENE$270,825
R01 · FY2001 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2001 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2001 · CA
CORE--ANIMAL$0
P01 · FY2001 · CA
BRCA GENES AND DNA REPAIR MACHINERY$0
P01 · FY2001 · CA
BRCA1 MALFUNCTION IN BREAST CANCER$0
P01 · FY2001 · CA
MOLECULAR BASIS OF RETINOBLASTOMA FORMATION$367,125
R01 · FY2000 · EY
CANCER SUPPRESSION BY THE RETINOBLASTOMA GENE$264,221
R01 · FY2000 · CA
BRCA1 MALFUNCTION IN BREAST CANCER$181,487
P01 · FY2000 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2000 · CA
TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENT$0
P50 · FY2000 · CA
CORE--ANIMAL$0
P01 · FY2000 · CA
BRCA GENES AND DNA REPAIR MACHINERY$0
P01 · FY2000 · CA